(Q44410467)

2 December 2017

0 references

Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study (English)

1 reference

functional magnetic resonance imaging

2 December 2017

1 reference

1

1 reference

2 December 2017

2

1 reference

2 December 2017

4

Klaus Willmes

1 reference

PubMed ID

12706227

Euphrosyne Gouzoulis-Mayfrank

2 December 2017

series ordinal

6

object named as

Euphrosyne Gouzoulis-Mayfrank

1 reference

2 December 2017

Bruno Fimm

3

1 reference

PubMed ID

12706227

2 December 2017

Armin Thron

series ordinal

5

1 reference

2 December 2017

1 May 2003

1 reference

2 December 2017

Cognitive Brain Research

1 reference

2 December 2017

16

1 reference

2 December 2017

3

1 reference

2 December 2017

479-487

1 reference

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Imaging cognition II: An empirical review of 275 PET and fMRI studies

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Prolonged reaction time to a verbal working memory task predicts increased power of posterior parietal cortical activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Toxic effect of MDMA on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Memory deficits associated with recreational use of "ecstasy" (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Neuropsychological performance in long-term cannabis users

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Working memory deficits in current and previous users of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0926-6410%2803%2900075-2

7 January 2021

10.1016/S0926-6410(03)00075-2

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12706227